OYM — Prostrate Cancer Genes Nucleic Acid Amplification Test System Class III

FDA Device Classification

FDA product code OYM covers "Prostrate Cancer Genes Nucleic Acid Amplification Test System", a Class III medical device. Submissions are reviewed by the Unknown panel.

Classification Details

Product Code
OYM
Device Class
Class III
Regulation Number
Submission Type
Review Panel
IM
Medical Specialty
Unknown
Implant
No

Definition

An in vitro nucleic acid amplification test that measures the concentration of prostate cancer genes.